The page is the record's research on the issuer — no analyst, no rating, no view. # Clene Inc. (NASDAQ: CLNN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Clene Inc., listed on NASDAQ under ticker CLNN, with ISIN US1856342019 and LEI not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 119 filings in the twelve months from 2025-11-08 to 2026-11-08, across 57 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-11-04, four days before the record date, and is of type results. The exchange median is 6.0 days cadence, 52 filings and 5.0 days latency across 4359 issuers. The sector median is 6.0 days cadence, 63.0 filings and 4.0 days latency across 526 issuers. By type, the record holds 69 directors' dealings, 20 regulatory filings, 14 corporate news, 9 results, 4 prospectuses, 2 AGM or EGM filings and 1 halt or suspension filing. ## Auditor The auditor of record is not on the record, because the latest annual report cover carries no dei:AuditorName tag, as foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds one delisting dated 2025-12-30. It holds no listing, name change or segment move on the record, and the domicile change is not on the record because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The orderability outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page; the count is 0. ## Open research No openly published research notes were found on the record; the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's sealed years are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001822791.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/CLNN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/CLNN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CLNN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp